Kestra Medical CBO acquires 227 shares via ESPP
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kestra Medical Technologies Chief Business Officer Timothy P. Moran acquired additional company stock through an employee purchase plan. He obtained 227 shares of common stock on June 30, 2026 at $21.55 per share under the 2025 Employee Stock Purchase Plan for the January 1–June 30, 2026 period. Following this ESPP purchase, he directly holds 42,488 shares of Kestra Medical Technologies common stock, which the disclosure states includes unvested restricted stock units.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 227 | $21.55 | $5K |
Footnotes (3)
- F1. Shares purchased pursuant to the Kestra Medical Technologies, Ltd. 2025 Employee Stock Purchase Plan ("ESPP") in transactions that were exempt under Rule 16b-3, for the ESPP purchase period of January 1, 2026 through June 30, 2026.
- F2. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 29, 2026.
- F3. Includes unvested RSUs.
Key Figures
Key Terms
Employee Stock Purchase Plan financial
ESPP financial
Rule 16b-3 regulatory
RSUs financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Kestra Medical (KMTS) report for Timothy P. Moran?
Was Timothy P. Moran’s Kestra Medical (KMTS) ESPP transaction a market trade?
AI-generated analysis. How Rhea-AI works. Not financial advice.